MZB1的可变剪接事件是乳腺癌内分泌治疗耐药的潜在生物标志物
张宇晴, 荆晶, 刘兆良, 安静, 安巍巍
The alternative splicing event of MZB1 is a potential biomarker of drug resistance in endocrine therapy of breast cancer
ZHANG Yuqing, JING Jing, LIU Zhaoliang, AN Jing, AN Weiwei
实用肿瘤学杂志
.
2024, (5): 313
-322
.
DOI: 10.11904/j.issn.1002-3070.2024.05.006
